Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmunity | 11 | 2025 | 238 | 2.100 |
Why?
|
| B-Lymphocytes | 12 | 2024 | 570 | 1.650 |
Why?
|
| Autoimmune Diseases | 7 | 2025 | 231 | 1.560 |
Why?
|
| Toll-Like Receptors | 8 | 2016 | 431 | 1.360 |
Why?
|
| Lymphocyte Activation | 14 | 2015 | 759 | 1.210 |
Why?
|
| Autoantigens | 7 | 2015 | 137 | 1.060 |
Why?
|
| Toll-Like Receptor 9 | 10 | 2016 | 211 | 1.050 |
Why?
|
| Receptors, Antigen, B-Cell | 7 | 2015 | 60 | 0.960 |
Why?
|
| Membrane Proteins | 5 | 2024 | 894 | 0.810 |
Why?
|
| Nucleic Acids | 3 | 2025 | 60 | 0.790 |
Why?
|
| Fas Ligand Protein | 5 | 2018 | 42 | 0.630 |
Why?
|
| Inflammation | 6 | 2025 | 1144 | 0.600 |
Why?
|
| DNA | 6 | 2015 | 835 | 0.580 |
Why?
|
| Mice | 26 | 2025 | 10844 | 0.500 |
Why?
|
| RNA | 5 | 2015 | 423 | 0.500 |
Why?
|
| Autoantibodies | 7 | 2015 | 182 | 0.500 |
Why?
|
| Animals | 32 | 2025 | 20656 | 0.470 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 15 | 0.440 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 212 | 0.410 |
Why?
|
| Toll-Like Receptor 7 | 4 | 2015 | 103 | 0.410 |
Why?
|
| Endothelial Cells | 1 | 2024 | 185 | 0.390 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2190 | 0.360 |
Why?
|
| Mice, Knockout | 13 | 2016 | 2109 | 0.360 |
Why?
|
| Endodeoxyribonucleases | 3 | 2016 | 45 | 0.350 |
Why?
|
| DNA-Binding Proteins | 3 | 2024 | 1182 | 0.340 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2013 | 164 | 0.330 |
Why?
|
| Lung | 2 | 2024 | 944 | 0.320 |
Why?
|
| Interferon Type I | 2 | 2019 | 186 | 0.320 |
Why?
|
| Rheumatoid Factor | 3 | 2015 | 13 | 0.320 |
Why?
|
| Immunologic Memory | 1 | 2011 | 290 | 0.320 |
Why?
|
| Epithelium, Corneal | 1 | 2018 | 6 | 0.300 |
Why?
|
| Keratitis | 1 | 2018 | 11 | 0.300 |
Why?
|
| Debridement | 1 | 2018 | 32 | 0.300 |
Why?
|
| Endosomes | 2 | 2016 | 178 | 0.280 |
Why?
|
| Flow Cytometry | 6 | 2016 | 669 | 0.270 |
Why?
|
| Mice, Transgenic | 7 | 2015 | 1281 | 0.250 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 34 | 0.250 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 29 | 0.250 |
Why?
|
| Antigen-Antibody Complex | 4 | 2010 | 52 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 7 | 2016 | 894 | 0.250 |
Why?
|
| Myeloid Cells | 1 | 2016 | 94 | 0.240 |
Why?
|
| Stromal Cells | 1 | 2016 | 67 | 0.240 |
Why?
|
| Epitopes | 1 | 2007 | 296 | 0.240 |
Why?
|
| Arthritis | 1 | 2015 | 53 | 0.240 |
Why?
|
| Cell Lineage | 1 | 2016 | 268 | 0.230 |
Why?
|
| Membrane Glycoproteins | 5 | 2015 | 669 | 0.220 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 285 | 0.220 |
Why?
|
| Dendritic Cells | 4 | 2015 | 524 | 0.210 |
Why?
|
| Cell Proliferation | 6 | 2015 | 983 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3394 | 0.200 |
Why?
|
| Ligands | 5 | 2015 | 416 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 125 | 0.200 |
Why?
|
| Retinal Ganglion Cells | 1 | 2011 | 30 | 0.180 |
Why?
|
| Glaucoma | 1 | 2011 | 59 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2010 | 41 | 0.170 |
Why?
|
| fas Receptor | 3 | 2012 | 57 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2010 | 217 | 0.170 |
Why?
|
| Cell Membrane | 2 | 2011 | 493 | 0.160 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 26 | 0.160 |
Why?
|
| Ovalbumin | 3 | 2014 | 116 | 0.150 |
Why?
|
| Apoptosis | 3 | 2013 | 1073 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1615 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 455 | 0.140 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2015 | 1351 | 0.120 |
Why?
|
| Interleukin-13 | 1 | 2015 | 37 | 0.120 |
Why?
|
| Interleukins | 1 | 2015 | 80 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 79 | 0.120 |
Why?
|
| Humans | 10 | 2025 | 63030 | 0.120 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 134 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 180 | 0.110 |
Why?
|
| Chromatin | 3 | 2010 | 608 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2156 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 77 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2024 | 200 | 0.100 |
Why?
|
| Interleukin-18 | 1 | 2012 | 74 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 140 | 0.100 |
Why?
|
| Caspase 8 | 1 | 2012 | 64 | 0.100 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 81 | 0.100 |
Why?
|
| Signal Transduction | 6 | 2015 | 3033 | 0.090 |
Why?
|
| Terpenes | 2 | 2016 | 27 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 264 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 236 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2011 | 83 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 641 | 0.080 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 23 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2019 | 29 | 0.080 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2015 | 54 | 0.080 |
Why?
|
| Interferon-alpha | 2 | 2006 | 102 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 60 | 0.080 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 377 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 166 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2009 | 80 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 542 | 0.080 |
Why?
|
| Corneal Neovascularization | 1 | 2018 | 2 | 0.080 |
Why?
|
| Corneal Stroma | 1 | 2018 | 9 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2018 | 35 | 0.080 |
Why?
|
| Mice, Inbred CBA | 2 | 2013 | 83 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2019 | 220 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2018 | 121 | 0.070 |
Why?
|
| Plasmids | 1 | 2018 | 292 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2018 | 611 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2013 | 302 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 364 | 0.070 |
Why?
|
| Transcriptome | 2 | 2015 | 388 | 0.070 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2016 | 12 | 0.060 |
Why?
|
| Models, Immunological | 1 | 2006 | 85 | 0.060 |
Why?
|
| Solubility | 2 | 2011 | 179 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2016 | 58 | 0.060 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2015 | 6 | 0.060 |
Why?
|
| Splenomegaly | 1 | 2015 | 24 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 716 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 644 | 0.060 |
Why?
|
| Syndecan-1 | 1 | 2015 | 9 | 0.060 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 43 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 517 | 0.060 |
Why?
|
| Antibody Specificity | 1 | 2015 | 103 | 0.060 |
Why?
|
| Plasma Cells | 1 | 2015 | 52 | 0.060 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2015 | 97 | 0.060 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 467 | 0.060 |
Why?
|
| Interferons | 1 | 2015 | 74 | 0.060 |
Why?
|
| Time Factors | 1 | 2011 | 3751 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 296 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 752 | 0.050 |
Why?
|
| Genotype | 1 | 2015 | 664 | 0.050 |
Why?
|
| Cell Line | 2 | 2010 | 2036 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2018 | 866 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 116 | 0.050 |
Why?
|
| Phenotype | 1 | 2015 | 1196 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2011 | 18 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2011 | 30 | 0.040 |
Why?
|
| Injections | 1 | 2011 | 81 | 0.040 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 27 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 42 | 0.040 |
Why?
|
| Cytokines | 2 | 2009 | 935 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 2014 | 167 | 0.040 |
Why?
|
| Female | 5 | 2018 | 32653 | 0.040 |
Why?
|
| Cell Communication | 1 | 2010 | 131 | 0.040 |
Why?
|
| Cell Death | 1 | 2011 | 284 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 431 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 937 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2005 | 10 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 613 | 0.040 |
Why?
|
| Microglia | 1 | 2011 | 242 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 692 | 0.030 |
Why?
|
| Protein Binding | 1 | 2011 | 1607 | 0.030 |
Why?
|
| Bleomycin | 1 | 2015 | 34 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2015 | 141 | 0.030 |
Why?
|
| Diphenylamine | 1 | 2014 | 4 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 2005 | 138 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 65 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 149 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 72 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2004 | 175 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2005 | 204 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 129 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 177 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2014 | 94 | 0.030 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2012 | 10 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 77 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 381 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 174 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 568 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 429 | 0.020 |
Why?
|
| Male | 3 | 2013 | 29655 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 377 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 84 | 0.020 |
Why?
|
| Peritoneum | 1 | 2000 | 29 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2000 | 176 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 454 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2012 | 334 | 0.020 |
Why?
|
| Cell Survival | 1 | 2000 | 573 | 0.020 |
Why?
|
| Binding Sites | 1 | 2000 | 903 | 0.020 |
Why?
|
| Tyrosine | 1 | 2007 | 94 | 0.020 |
Why?
|
| Neutrophils | 1 | 2000 | 376 | 0.020 |
Why?
|
| Hybridomas | 1 | 2005 | 64 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 469 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 114 | 0.010 |
Why?
|
| Calcium | 1 | 2007 | 573 | 0.010 |
Why?
|
| Receptors, Complement 3b | 1 | 2002 | 12 | 0.010 |
Why?
|
| Receptors, Complement 3d | 1 | 2002 | 16 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2002 | 41 | 0.010 |
Why?
|